These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

640 related articles for article (PubMed ID: 18465517)

  • 1. Cystemustine INSERM.
    Palmer B
    IDrugs; 1998 May; 1(1):129-35. PubMed ID: 18465517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian rhythm in toxic effects of cystemustine in mice: relevance for chronomodulated delivery.
    Martineau-Pivoteau N; Levi F; Rolhion C; Kwiatkowski F; Lemaigre G; Filipski E; Chollet P
    Int J Cancer; 1996 Nov; 68(5):669-74. PubMed ID: 8938151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models.
    Rapp M; Maurizis JC; Papon J; Labarre P; Wu TD; Croisy A; Guerquin-Kern JL; Madelmont JC; Mounetou E
    J Pharmacol Exp Ther; 2008 Jul; 326(1):171-7. PubMed ID: 18411412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes.
    Cussac C; Rapp M; Mounetou E; Madelmont JC; Maurizis JC; Godeneche D; Dupuy JM; Sauzieres J; Baudry JP; Veyre A
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1353-8. PubMed ID: 7996446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and metabolism of O6-alkylguanine-DNA alkyltransferase inhibitor in nude mice bearing human melanoma.
    Cussac C; Mounetou E; Rapp M; Madelmont JC; Maurizis JC; Labarre P; Chollet P; Chabard JL; Godeneche D; Baudry JP
    Drug Metab Dispos; 1994; 22(4):637-42. PubMed ID: 7956741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
    Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
    Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement by O6-benzyl-N2-acetylguanosine of N'-[2-chloroethyl]-N-[2-(methylsulphonyl)ethyl]-N'-nitrosourea therapeutic index on nude mice bearing resistant human melanoma.
    Debiton E; Cussac-Buchdhal C; Mounetou E; Rapp M; Dupuy JM; Maurizis JC; Veyre A; Madelmont JC
    Br J Cancer; 1997; 76(9):1157-62. PubMed ID: 9365163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronopharmacology and chronotherapy of cancers].
    Lévi F
    Pathol Biol (Paris); 1996 Sep; 44(7):631-44. PubMed ID: 8977920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities.
    Hansen RJ; Nagasubramanian R; Delaney SM; Cherian MM; Lin S; Kogan SC; Dolan ME
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1247-55. PubMed ID: 16126841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
    Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC
    Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modulation of the antitumor activity of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosoure a by O(6)-methyl-2'-deoxyguanosine--a new inhibitor of O(6)-alkylguanine-DNA-alkyltransferase].
    Dederer LIu; Sokolova IS; Bakhmedova AA; Miniker TD; Mel'nik SIa; Gorbacheva LB
    Biokhimiia; 1995 Sep; 60(9):1521-9. PubMed ID: 8562657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer.
    Caponigro F; Avallone A; McLeod H; Cartenì G; De Vita F; Casaretti R; Morsman J; Blackie R; Budillon A; De Lucia L; Gravina A; Catalano G; Comella P; Comella G
    Clin Cancer Res; 1999 Dec; 5(12):3948-55. PubMed ID: 10632324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics.
    Lévi F; Focan C; Karaboué A; de la Valette V; Focan-Henrard D; Baron B; Kreutz F; Giacchetti S
    Adv Drug Deliv Rev; 2007 Aug; 59(9-10):1015-35. PubMed ID: 17692427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered O6-alkylguanine-DNA alkyltransferase activity in cell strains originating from mouse skin tumors induced by UV irradiation.
    Nishigori C; Moriwaki S; Yagi T; Takebe H
    Cancer Res; 1991 May; 51(9):2425-9. PubMed ID: 1826632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-amino-O4-benzylpteridine derivatives: potent inactivators of O6-alkylguanine-DNA alkyltransferase.
    Nelson ME; Loktionova NA; Pegg AE; Moschel RC
    J Med Chem; 2004 Jul; 47(15):3887-91. PubMed ID: 15239666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
    Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
    Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[(methylamino)carbonyl]hydrazine (VNP40101M): II. Role of O6-alkylguanine-DNA alkyltransferase in cytotoxicity.
    Baumann RP; Shyam K; Penketh PG; Remack JS; Brent TP; Sartorelli AC
    Cancer Chemother Pharmacol; 2004 Apr; 53(4):288-95. PubMed ID: 14685775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. O6-alkylguanine-DNA alkyltransferase in cutaneous T-cell lymphoma: implications for treatment with alkylating agents.
    Dolan ME; McRae BL; Ferries-Rowe E; Belanich M; van Seventer GA; Guitart J; Pezen D; Kuzel TM; Yarosh DB
    Clin Cancer Res; 1999 Aug; 5(8):2059-64. PubMed ID: 10473086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.